These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 19616482)

  • 21. Termination of absence status epilepticus by low-dose intravenous levetiracetam.
    Altenmüller DM; Kühn A; Surges R; Schulze-Bonhage A
    Epilepsia; 2008 Jul; 49(7):1289-90. PubMed ID: 18638286
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimyoclonic effect of levetiracetam.
    Genton P; Gélisse P
    Epileptic Disord; 2000 Dec; 2(4):209-12. PubMed ID: 11174151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
    Kim JS; Lee JH; Ryu HW; Lim BC; Hwang H; Chae JH; Choi J; Kim KJ; Hwang YS; Kim H
    Pediatr Emerg Care; 2014 Aug; 30(8):525-8. PubMed ID: 25062293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F; Ozcay F; Haberal M
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.
    Rüegg S; Naegelin Y; Hardmeier M; Winkler DT; Marsch S; Fuhr P
    Epilepsy Behav; 2008 Apr; 12(3):477-80. PubMed ID: 18291724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
    Trabacca A; Profice P; Costanza MC; Gesualdi M; De Rinaldis M
    J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus.
    Wheless JW; Treiman DM
    Epilepsia; 2008 Dec; 49 Suppl 9():74-8. PubMed ID: 19087120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan.
    Tanabe T; Awaya Y; Matsuishi T; Iyoda K; Nagai T; Kurihara M; Yamamoto K; Minagawa K; Maekawa K
    Brain Dev; 2008 Nov; 30(10):629-35. PubMed ID: 18424028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
    Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
    Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with levetiracetam in the treatment of status epilepticus].
    Rösche J; Pohley I; Rantsch K; Walter U; Benecke R
    Fortschr Neurol Psychiatr; 2013 Jan; 81(1):21-7. PubMed ID: 22890440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
    Cilio MR; Bianchi R; Balestri M; Onofri A; Giovannini S; Di Capua M; Vigevano F
    Epilepsy Res; 2009 Sep; 86(1):66-71. PubMed ID: 19520548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus.
    Treiman DM; Walker MC
    Epilepsy Res; 2006 Jan; 68 Suppl 1():S77-82. PubMed ID: 16384688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
    Gibbs JE; Walker MC; Cock HR
    Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model.
    Gibbs JE; Cock HR
    Epilepsy Res; 2007 Feb; 73(2):208-12. PubMed ID: 17085017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IV levetiracetam in the management of non-convulsive status epilepticus.
    Farooq MU; Naravetla B; Majid A; Gupta R; Pysh JJ; Kassab MY
    Neurocrit Care; 2007; 7(1):36-9. PubMed ID: 17657655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of levetiracetam on visual-spatial memory following status epilepticus.
    Zhou JL; Zhao Q; Holmes GL
    Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study.
    Aiguabella M; Falip M; Villanueva V; de la Peña P; Molins A; Garcia-Morales I; Saiz RA; Pardo J; Tortosa D; Sansa G; Miró J
    Seizure; 2011 Jan; 20(1):60-4. PubMed ID: 21145758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.